Stock Ratings / Health Care / MO / forecast

BTI (66) PM (81) DFTX (52) RGC (38) ⌘ Pro Terminal →

Altria Group Inc. (MO) 12-Month Stock Forecast & Price Target Cone

$78.03 +1.67% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $78.45

Altria Group Inc. (MO) earns a Roarable Rating of A (Strong Buy) with 89/100 RQD Confidence. High-quality cash engine (63% profit margin, 48% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 89/100 (A) historically ranked in the Top 4% of excess returns over the next 90 days (+9.7% avg 90D alpha vs SPY • 74.2% hit rate) →

ROARABLE A • STRONG BUY Cap $128.15B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MO Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is MO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Altria Group Inc. (NYSE: MO) is rated A (Strong Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 89/100 at a spot price of $78.03 (+1.67% 1D, market cap $128.15B). Pillar breakdown: Fundamental Cash Engine 20/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 19/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, MO ranks #1 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does MO compare to BTI and PM in the Health Care sector?

▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), MO carries a Roarable A (89/100 RQD), trailing P/E of 18.4x, gross margin of 62.5%, and ROIC of 48.4%. By comparison, BTI (British American Tobacco Industries p.l.c. ADR) holds a C+ grade (66/100 RQD, P/E 32.8x, ROIC 9.9%, cap $131.93B) and PM (Philip Morris International Inc) posts a A- grade (81/100 RQD, P/E 28.6x, ROIC 45.3%, cap $324.98B). Among the 5-stock peer group, MO leads on earnings multiple (18.4x) while MO leads on capital efficiency (48.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MO?

▼

Per MO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000764180), Altria Group Inc. generated $23.28B in revenue (-3.1% YoY), $6.95B in net income, and $9.07B in free cash flow against $35.02B in total assets and $24.14B in total debt. Key quantitative strengths: Strong cash generator (63% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $78.45 (+0.54%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 20/20 (A+) • 39% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 89/100 (A) historically ranked in the Top 4% of excess returns over the next 90 days (+9.7% avg 90D alpha vs SPY • 74.2% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSTRONG BUY • A

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw A · Rk A

Each axis scored 0–20

12M PRICE TARGET CONE+14% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MO)Realized 20D OHLCV Swing Band: ±4.8%

Deterministic 5-Pillar Attribution (89/100 Composite)

🔍 WHY MO SCORES 89/100 (A) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+20/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 39% FCF Margin ($9.07B FCF) & 62.5% Gross Margin

▲ #2 Bullish Driver: Macro Regime Fit+19/20 pts (21% of score)

FRED Regime × Technicals: 93% of 52W Range • RSI-14 at 63.7 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution16/20 pts (-4 pt drag)

Cannibal Buyback (-2.36% YoY Shares) & executive Form 4 sales trim 4 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade A-$71.56+4.3% Next Q

Q2 (-2Q)

Grade A$74.64-1.5% Next Q

Q3 (-1Q)

Grade A$73.49+6.2% Next Q

Current

Grade A$78.03+9.7% Hist 90D α

Trajectory: A- (81) → A (89)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the MO Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 89/100 (A) score, MO faces multiple-compression risk if 18.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 60.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($70.84) or 200D SMA ($69.03) invalidates the momentum regime and cuts Target Base ($88.92) toward Bear Floor ($63.98).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MO• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MO Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 89%NO 11%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your MO Position Size: $10,000

Shares at $78.03: 128.2 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $63.98

$8,199

$-1,801 (-18.0%)

12M Consensus BaseTarget $88.92

$11,396

+$1,396 (+14.0%)

12M Bull Case BreakoutTarget $104.93

$13,447

+$3,447 (+34.5%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (43 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 32● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	OUTPERFORM	$92	74%	A
Goldman SachsSector Coverage Lead	STRONG BUY	$99	69%	B
JP MorganUS Large-Cap Research	HOLD	$76	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (MO Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +6.29%▲ ASCENDING CHANNEL

2026-11-02O $72.99H $78.03L $72.99C $78.03VOL 12.53M

RES: $79.89SUP: $66.93SMA50: $70.84SMA200: $69.03

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MO Butterfly Map → + Track MO →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

11.7%/yr Implied 5Y Growth

vs. -3.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MO today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MO. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MO)

Health Care Rank #1 of 1016 ⚔️ BTI vs MO Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MO vs. BTI, PM, DFTX, RGC)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Altria Group Inc. (MO) ranks #1 by composite RQD confidence (89/100, grade A) and #17 by equity capitalization ($128.15B). Within this direct 5-issuer industry benchmark cohort, MO leads on earnings valuation at 18.4x trailing P/E, while MO leads on capital efficiency and profitability with 48.4% ROIC and 62.5% gross margin. MO currently leads its immediate peer cohort in composite quantitative strength at 89/100 (A).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MO ACTIVE Altria Group Inc.	A	89/100	18.4x	62.5%	48.4%	+1.67%	$128.15B	Benchmark Subject
BTI British American Tobacco Industries p.l.c. ADR	C+	66/100	32.8x	—	9.9%	+0.74%	$131.93B	/bti-vs-mo →
PM Philip Morris International Inc	A-	81/100	28.6x	67.1%	45.3%	+0.14%	$324.98B	/pm-vs-mo →
DFTX Definium Therapeutics Inc.	D+	52/100	—	—	-32.2%	-4.29%	$5.10B	/dftx-vs-mo →
RGC Regencell Bioscience Holdings Limited	D-	38/100	—	—	—	-2.19%	$3.40B	/rgc-vs-mo →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000764180

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Altria Group Inc. (MO) reported GAAP revenue of $23.28B (-3.1% vs. FY2024 revenue of $24.02B , and -4.9% cumulative change since FY2023) , GAAP net income of $6.95B, operating cash flow of $9.29B, and free cash flow of $9.07B (+5.4% YoY). On the balance sheet, MO closed FY2025 with $35.02B in total assets against $24.14B in total debt (Altman Z-Score: 4.90, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$23.28B	$6.95B	$9.29B	$9.07B	$35.02B	$24.14B
FY2024 (FY)	2024-12-31	$24.02B	$11.26B	$8.75B	$8.61B	$35.18B	$23.40B
FY2023 (FY)	2023-12-31	$24.48B	$8.13B	$9.29B	$8.19B	$70.48B	$16.49B

3. MO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does MO compare to BTI and PM in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for MO?

Where is MO trading relative to its 50-day, 200-day, and 52-week technical levels?

MO last traded at $78.03 (+1.67% on volume of 20,522,891 shares), positioning the stock +10.15% above its 50-day simple moving average ($70.84) and +13.04% above its 200-day simple moving average ($69.03). Across its 52-week range of $54.70 to $79.81, MO sits at the 92.9% percentile with a 14-day RSI of 63.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±4.8% ($74.28 to $81.78).

MO Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is MO's 12-month stock price target?

Altria Group Inc. (MO) carries a 12-month consensus base price target of $88.92 (+14% from $78.03), with a bull-case target of $104.93 and a bear-case floor of $63.98.

Is MO stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates MO A (Strong Buy — BUY) with an RQD Confidence score of 89/100.

Direct Sub-Reports: MO RQD Cockpit MO 12M Forecast MO Earnings & Move MO Dividends & DRIP MO Insiders & 13F MO Whale Options MO Profit Sankey MO News & Why

ROARABLE RATING BRIEF • RQD 89/100 (A) ✓ STAGE-C NUMBER FIREWALL VERIFIED

MO — Altria Group Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:09:28Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, MO scores 89 out of 100, grade A, labeled "Roarable Strong Buy — Excellent Cash & Whale Support." The five pillars are:

Fundamental Cash Engine (20/20): The highest possible score, citing ROIC of 48.4% and an FCF yield of 7.08%. For a prospective investor, this indicates the business converts capital into cash at a high rate, which is the core driver of the rating.
Whale 13F Flow (18/20): Scored on institutional accumulation and options positioning. This suggests large holders have been net supportive, though the rating does not specify the magnitude of flows in the supplied data.
Insider Conviction (16/20): Based on SEC Form 4 and Congressional PTR cluster flow. The score is solid but below the top tier, indicating insider activity is supportive without being exceptional.
Macro Regime Fit (19/20): Reflects Beta of 0.92 and sector sensitivity. A beta below 1.0 implies the stock has historically moved less than the broad market, which may appeal to investors seeking lower volatility, though this is a backward-looking measure.
Forensic Balance Sheet (16/20): Supported by Altman Z-Score of 4.9, Piotroski F-Score of 6/9, and Debt/Equity of 0.85. These point to a financially sound balance sheet with moderate leverage.

Investor implications: the rating's strength rests heavily on cash generation and capital efficiency. Upside drivers include continued high FCF and institutional support. Valuation tradeoffs are visible in the snapshot: trailing P/E of 18.4 and forward P/E of 17.1 are not extreme, but the stock has moved near its 52-week high. An investor should weigh whether current pricing already reflects the strength captured in the score. The rating is a model output and does not guarantee future performance.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
76.75	$128.15B	18.4	17.1	14.7	4.16	5.43%	0.92	$54.7 - $79.81	48.4%

Business

Altria Group Inc. is a NYSE-listed issuer in the Health Care sector, operating within the Medicinal Chemicals and Botanical Products industry, per the company profile. Market capitalization is $128.2B per the profile. Source data does not provide a detailed description of product lines, customer base, or revenue model beyond the sector and industry classification.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$23279.0M	$9899.0M	$6947.0M	N/A	$9074.0M	$4474.0M	$24140.0M
FY 2024	$24018.0M	$11241.0M	$11264.0M	N/A	$8611.0M	$3127.0M	$23399.0M
FY 2023	$24483.0M	$11547.0M	$8130.0M	N/A	$8185.3M	N/A	$16493.3M

Per the market data, gross margin is 62.5%, operating margin 42.5%, and net margin 29.8%, with ROIC of 48.4%. Per the RQD rating, the Altman Z-Score is 4.9 and the Piotroski F-Score is 6/9, with Debt/Equity of 0.85. Reported revenue declined from $24483.0M (FY 2023) to $23279.0M (FY 2025), while free cash flow rose from $8185.3M to $9074.0M over the same span. FY 2025 debt of $24140.0M exceeds reported cash of $4474.0M.

Recent Catalysts & News Wire Analysis

Per the recent news feed, six items are listed for MO, all from news aggregators:

Yahoo Finance: a report headlined that the stock could be undervalued on cash flow (YELLOW).
Trefis: a report questioning whether a new high should deter buyers (YELLOW).
TradingKey: a report on a single-day gain of 3.45% on Oct 8 (YELLOW).
Seeking Alpha: a report stating the rally is running ahead of underlying earnings growth (GREEN, classified as CATALYST).
Yahoo Finance: a report on the stock rising as the market dipped (YELLOW).
Trefis: a report noting five consecutive gain days with the stock up 6.7% (YELLOW).

The Seeking Alpha item is the only one flagged GREEN and as a catalyst. The remaining items are market wire coverage. Risk watch item: the Seeking Alpha headline itself raises the question of whether price action is outpacing earnings growth. Per the Butterfly Supply-Chain Graph, supply chain status is NONE, with no butterfly links or proprietary signals listed.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, there are no upstream or downstream links, no sector correlations, and no proprietary signals. Not available in source data for dependency mapping, sector correlations, or 2nd-order bottlenecks.

Open Questions

What specific revenue drivers explain the decline from $24483.0M (FY 2023) to $23279.0M (FY 2025), and does the source data support a trend view beyond three periods?
Why is EPS reported as N/A across all periods, and how does it reconcile with net income and the TTM EPS of 4.16?
What is the composition of the $24140.0M debt and its maturity schedule relative to the $4474.0M cash balance?
Which institutional holders and insider transactions underpin the 18/20 Whale and 16/20 Insider pillar scores, since no holder data is supplied?
What analyst price targets or consensus rating exist to compare against the current $76.75 price?

MO Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Altria Group Inc. (MO) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to MO Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 4h ago

Altria Group (MO) Stock Could Be 50% Undervalued On Cash Flow

Yahoo Finance report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Trefis • 7h ago

Should Altria Stock’s New High Stop You From Buying?

Trefis report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 10h ago

Altria Group Inc Stock (MO) Moved Up by 3.45% on Oct 8: What Investors Need To Know

TradingKey report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 13h ago

Altria: The Rally Looks Ahead Of Underlying Earnings Growth

Seeking Alpha report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 16h ago

Altria (MO) Rises As Market Takes a Dip: Key Facts

Yahoo Finance report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Trefis • 19h ago

5 Green Days In A Row: Altria Stock Is Up 6.7%

Trefis report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 22h ago

Altria (MO) stock is up, what you need to know

Yahoo Finance report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Trefis • 1d ago

Do Altria’s Dividends Make Up For A Lagging Stock?

Trefis report covering Altria Group Inc. (MO) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

MO Bull vs. Bear Conversation Board — What's Your Call at $78.03?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MO 🐻 33% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH 🎯 Target: $90.57 (+18.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is MO (A • RQD 89/100) a Buy at $76.75?

Welcome to the MO (Altria Group Inc.) Roar Pit. Current RQD Composite is 89/100 (Roarable Strong Buy — Excellent Cash & Whale Support) in Medicinal Chemicals and Botanical Products. Bulls point to capital efficiency (48.4% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $57.56 (-25.0%)

Spot @ $76.75

Pump the brakes on MO — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on MO, but look at what you are paying: 18.4x trailing P/E with 62.5% gross margins. Unless Altria Group Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $90.57 (+18.0%)

Spot @ $76.75

MO cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on MO, the market is fixating on short-term headline noise in Medicinal Chemicals and Botanical Products and ignoring the balance sheet and cash flow trajectory. At $76.75 (52-wk range $54.70 - $79.81), any beat on forward guidance forces shorts and underweight funds to chase.